Skip to main navigation
Decibel Therapeutics logo
Menu Button

Top Menu

  • JOIN US
  • CONTACT US

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Patients & Families
    • Genetic Testing
    • Patients and Families
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us

SEC Filings

Filing date Form Description View
March 29, 2021 10-K

Annual report which provides a comprehensive overview of the company for the past year

0001564590-21-016167.pdf
0001564590-21-016167.rtf
0001564590-21-016167.xls
View HTML
March 18, 2022 10-K

Annual report which provides a comprehensive overview of the company for the past year

0000950170-22-004130.pdf
0000950170-22-004130.rtf
0000950170-22-004130.xls
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT View HTML
May 13, 2021 10-Q

Quarterly report which provides a continuing view of a company's financial position

0001564590-21-027531.pdf
0001564590-21-027531.rtf
0001564590-21-027531.xls
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
August 10, 2021 10-Q

Quarterly report which provides a continuing view of a company's financial position

0001564590-21-042863.pdf
0001564590-21-042863.rtf
0001564590-21-042863.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 10, 2021 10-Q

Quarterly report which provides a continuing view of a company's financial position

0000950170-21-003892.pdf
0000950170-21-003892.rtf
0000950170-21-003892.xls
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT View HTML
May 12, 2022 10-Q

Quarterly report which provides a continuing view of a company's financial position

0000950170-22-009447.pdf
0000950170-22-009447.rtf
0000950170-22-009447.xls
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT View HTML
February 11, 2021 3

Initial filing by director officer or owner of more than ten percent.

0001104659-21-020783.pdf
0001104659-21-020783.rtf
0001104659-21-020783.xls
View HTML
February 11, 2021 3

Initial filing by director officer or owner of more than ten percent.

0001209191-21-009791.pdf
0001209191-21-009791.rtf
0001209191-21-009791.xls
View HTML
February 11, 2021 3

Initial filing by director officer or owner of more than ten percent.

0001209191-21-009799.pdf
0001209191-21-009799.rtf
0001209191-21-009799.xls
View HTML
February 11, 2021 3

Initial filing by director officer or owner of more than ten percent.

0001209191-21-009803.pdf
0001209191-21-009803.rtf
0001209191-21-009803.xls
View HTML

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Displaying 1 - 10 of 106 results

Data provided by Kaleidoscope.

Shareholder Tools

Contact IR
Contact IR
Email Alerts
Email Alerts
Print Page
Print Page
RSS Feeds
RSS Feeds
Search
Search

© Decibel Therapeutics, Inc. 2022. All rights reserved.

  • Privacy Notice
  • Terms of Use
  • Twitter
  • LinkedIn

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Patients & Families
    • Genetic Testing
    • Patients and Families
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us